tradingkey.logo
tradingkey.logo
Search

Zimmer Biomet Holdings Inc

ZBH
Add to Watchlist
105.590USD
-1.260-1.18%
Close 11-06 16:00(ET)
20.14BMarket Cap
27.30P/E TTM
After-hours 19:00 (ET)105.590USD+0.130+0.12%

Today

-1.18%

5 Days

+11.71%

1 Month

+17.74%

6 Months

+28.15%

Year to Date

+18.37%

1 Year

+20.57%

Key Figures

103.210Open
111.210High
723.31KVolume
27.30P/E TTM
11.65P/E Dynamic
0.960Dividend TTM
0.38%Turnover Ratio
106.850Prev. Close
103.210Low
76.31MTurnover
22.28P/E Static
1.58P/B
0.91%Div Yield TTM
3.39%ROA
112.54552wk High
80.95Volume Ratio
903.80MNet Profit
190.74MShares
3.8671EPS TTM
0.48Beta
6.07%ROE
78.70352wk Low
7.49%Amplitude
63.13%Gross Margin
20.14BMarket Cap
8.03Reward/Risk
2.03%Risk Rate

Zimmer Biomet Holdings Inc's Score

-0.05vs previous score
Forecast6.67
Financial Health7.88
Technical4.63
Valuation Dimensions8.54
Institutional Confidence10.00
Risk Assessment7.66

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
HoldCurrent Rating
106.635Target Price
+12.82%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy22233223
Buy56666666
Hold2020211919201919
Sell00022333
Strong Sell00000000

Zimmer Biomet Holdings Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy

Zimmer Biomet Holdings Inc Latest Earnings Call Transcripts

Zimmer Biomet (ZBH) Q3 2026 Earnings Call: Guidance Raised as Hips and S.E.T. Grow

Zimmer Biomet Q3 2026 sales rose 3.1% to $2.63 billion as Hips and S.E.T. offset Knee weakness. ZBH raised its 2026 sales and EPS guidance.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
1.01/1.88
Revenue / Forecast
2.06B/2.04B

Zimmer Biomet Holdings Inc Profile

SectorHealthcare Equipment & Supplies
Ticker SymbolZBH
Number of employees17000
CountryUnited States of America

Ownership

ShareholdersProportion
Dodge & Cox12.15%
T. Rowe Price Associates, Inc.6.89%
Vanguard Capital Management, LLC6.61%
Harris Associates L.P.6.34%
Shareholder TypesProportion
Investment Advisor54.59%
Investment Advisor/Hedge Fund46.04%
Research Firm1.92%
Hedge Fund1.78%

FAQs

What is the current price of Zimmer Biomet Holdings Inc (ZBH)?

The current price of Zimmer Biomet Holdings Inc (ZBH) is 105.59.

What is the symbol of Zimmer Biomet Holdings Inc?

The ticker symbol of Zimmer Biomet Holdings Inc is ZBH.

What is the 52-week high of Zimmer Biomet Holdings Inc?

The 52-week high of Zimmer Biomet Holdings Inc is 112.55.

What is the 52-week low of Zimmer Biomet Holdings Inc?

The 52-week low of Zimmer Biomet Holdings Inc is 78.70.

What is the market capitalization of Zimmer Biomet Holdings Inc?

The market capitalization of Zimmer Biomet Holdings Inc is 20.14B.

Is Zimmer Biomet Holdings Inc (ZBH) currently rated as Buy, Hold, or Sell?

According to analysts, Zimmer Biomet Holdings Inc (ZBH) has an overall rating of signal_hold, with a price target of 106.64.

What is the Earnings Per Share (EPS TTM) of Zimmer Biomet Holdings Inc (ZBH)?

The Earnings Per Share (EPS TTM) of Zimmer Biomet Holdings Inc (ZBH) is 3.87.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.